Healthcare services are designed to promote health, prevent illness and treat disease. However, these settings may inadvertently become a source of infection, leading to unintended adverse health outcomes. Hospital-acquired infections (HAIs) represent a significant and often overlooked threat in modern healthcare.
HAIs are infections that patients acquire while receiving treatment for other conditions within a healthcare setting. They are a major cause of morbidity and mortality worldwide, with millions of patients affected each year. These infections not only compromise patient safety but also incur substantial costs related to prolonged hospital stays, additional diagnostic tests, and treatment.
The most common types of HAIs include: central line-associated bloodstream infections, catheter-associated urinary tract infections, surgical site infections, and ventilator-associated pneumonia. These infections are often caused by multi-drug resistant organisms, which further complicates their management and control.
Preventing HAIs requires a comprehensive approach that includes infection control practices, antimicrobial stewardship, and healthcare worker education. Infection control practices such as hand hygiene, use of personal protective equipment, and environmental cleaning are crucial. Antimicrobial stewardship programs aim to optimize the use of antimicrobials to reduce resistance. Lastly, ongoing education and training of healthcare workers can ensure adherence to these measures.
HAIs remain a significant challenge in modern healthcare, necessitating a multifaceted approach to effectively combat this silent threat. By recognizing the burden of HAIs and implementing rigorous prevention and control measures, healthcare institutions can significantly reduce the incidence of these infections, thereby improving patient outcomes and reducing healthcare costs.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation